Cargando…

The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population

OBJECTIVE: We examined whether the single-nucleotide polymorphism (SNP) rs13181 in the gene encoding excision repair cross complementation group 2 (ERCC2) is associated with the risk and prognosis of nasopharyngeal carcinoma (NPC). METHODS: SNPs at rs13181 were genotyped in 439 NPC patients (NPC gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zhengbo, Yao, Mengwei, Ning, Sisi, Wu, Yuan, Zhou, Xunzhao, Zhong, Changtao, Yan, Kui, Xie, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982703/
https://www.ncbi.nlm.nih.gov/pubmed/33762840
http://dx.doi.org/10.2147/PGPM.S296215
_version_ 1783667775167791104
author Wei, Zhengbo
Yao, Mengwei
Ning, Sisi
Wu, Yuan
Zhou, Xunzhao
Zhong, Changtao
Yan, Kui
Xie, Ying
author_facet Wei, Zhengbo
Yao, Mengwei
Ning, Sisi
Wu, Yuan
Zhou, Xunzhao
Zhong, Changtao
Yan, Kui
Xie, Ying
author_sort Wei, Zhengbo
collection PubMed
description OBJECTIVE: We examined whether the single-nucleotide polymorphism (SNP) rs13181 in the gene encoding excision repair cross complementation group 2 (ERCC2) is associated with the risk and prognosis of nasopharyngeal carcinoma (NPC). METHODS: SNPs at rs13181 were genotyped in 439 NPC patients (NPC group) and 431 age- and gender-matched cancer-free controls (control group) from a region of China where NPC is endemic, and frequencies of GG, GT and TT genotypes were compared between the two groups in the case–control study. In a subset of 365 NPC cases, SNPs were examined for potential correlation with tumor-free survival time (TFS) and overall survival (OS). RESULTS: Relative to NPC risk with a TT genotype, NPC risk was similar with GT + GG genotypes (OR 1.052, 95% CI 0.656–1.688), after adjusting for gender, age, smoking history, and immunoglobin A against Epstein-Barr virus capsid antigen (EBV-VCA-IgA) status. Univariate analysis showed that the GG or GT genotype was associated with significantly worse TFS (p<0.001) and OS (p=0.010) than the TT genotype. Prognosis was significantly worse for men than for women (TFS, p=0.045; OS, p=0.031), for T3–T4 classification than for T1–T2 (TFS, p=0.009; OS, p=0.007), for N3 than for N0+N1+N2 (TFS, p<0.001; OS, p<0.001). Based on multivariate analysis, independent risk factors for poor TFS were GG or GT genotype (HR 2.629, 95% CI 1.625–4.254, p<0.001), T3–T4 classification (HR 2.146, 95% CI 1.244–3.701, p=0.006) and N3 (HR 2.527, 95% CI 1.574–4.059, p<0.001). GG or GT genotype (HR 2.217, 95% CI 1.283–3.832, p=0.004), gender (HR 1.989, 95% CI 1.046–3.785, p=0.036), T3–T4 (HR 2.431, 95% CI 1.306–4.526, p=0.005) and N3 (HR 2.693, 95% CI 1.637–4.432, p<0.001) were independent risk factors for poor OS. CONCLUSION: The rs13181 SNP in ERCC2 does not appear to be associated with NPC risk, but it may serve as an independent prognostic factor for NPC recurrence and death.
format Online
Article
Text
id pubmed-7982703
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79827032021-03-23 The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population Wei, Zhengbo Yao, Mengwei Ning, Sisi Wu, Yuan Zhou, Xunzhao Zhong, Changtao Yan, Kui Xie, Ying Pharmgenomics Pers Med Original Research OBJECTIVE: We examined whether the single-nucleotide polymorphism (SNP) rs13181 in the gene encoding excision repair cross complementation group 2 (ERCC2) is associated with the risk and prognosis of nasopharyngeal carcinoma (NPC). METHODS: SNPs at rs13181 were genotyped in 439 NPC patients (NPC group) and 431 age- and gender-matched cancer-free controls (control group) from a region of China where NPC is endemic, and frequencies of GG, GT and TT genotypes were compared between the two groups in the case–control study. In a subset of 365 NPC cases, SNPs were examined for potential correlation with tumor-free survival time (TFS) and overall survival (OS). RESULTS: Relative to NPC risk with a TT genotype, NPC risk was similar with GT + GG genotypes (OR 1.052, 95% CI 0.656–1.688), after adjusting for gender, age, smoking history, and immunoglobin A against Epstein-Barr virus capsid antigen (EBV-VCA-IgA) status. Univariate analysis showed that the GG or GT genotype was associated with significantly worse TFS (p<0.001) and OS (p=0.010) than the TT genotype. Prognosis was significantly worse for men than for women (TFS, p=0.045; OS, p=0.031), for T3–T4 classification than for T1–T2 (TFS, p=0.009; OS, p=0.007), for N3 than for N0+N1+N2 (TFS, p<0.001; OS, p<0.001). Based on multivariate analysis, independent risk factors for poor TFS were GG or GT genotype (HR 2.629, 95% CI 1.625–4.254, p<0.001), T3–T4 classification (HR 2.146, 95% CI 1.244–3.701, p=0.006) and N3 (HR 2.527, 95% CI 1.574–4.059, p<0.001). GG or GT genotype (HR 2.217, 95% CI 1.283–3.832, p=0.004), gender (HR 1.989, 95% CI 1.046–3.785, p=0.036), T3–T4 (HR 2.431, 95% CI 1.306–4.526, p=0.005) and N3 (HR 2.693, 95% CI 1.637–4.432, p<0.001) were independent risk factors for poor OS. CONCLUSION: The rs13181 SNP in ERCC2 does not appear to be associated with NPC risk, but it may serve as an independent prognostic factor for NPC recurrence and death. Dove 2021-03-17 /pmc/articles/PMC7982703/ /pubmed/33762840 http://dx.doi.org/10.2147/PGPM.S296215 Text en © 2021 Wei et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wei, Zhengbo
Yao, Mengwei
Ning, Sisi
Wu, Yuan
Zhou, Xunzhao
Zhong, Changtao
Yan, Kui
Xie, Ying
The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
title The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
title_full The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
title_fullStr The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
title_full_unstemmed The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
title_short The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
title_sort association of single-nucleotide polymorphism rs13181 in ercc2 with risk and prognosis of nasopharyngeal carcinoma in an endemic chinese population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982703/
https://www.ncbi.nlm.nih.gov/pubmed/33762840
http://dx.doi.org/10.2147/PGPM.S296215
work_keys_str_mv AT weizhengbo theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT yaomengwei theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT ningsisi theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT wuyuan theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT zhouxunzhao theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT zhongchangtao theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT yankui theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT xieying theassociationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT weizhengbo associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT yaomengwei associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT ningsisi associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT wuyuan associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT zhouxunzhao associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT zhongchangtao associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT yankui associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation
AT xieying associationofsinglenucleotidepolymorphismrs13181inercc2withriskandprognosisofnasopharyngealcarcinomainanendemicchinesepopulation